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Abstract:  
Background: It remains difficult to predict and prevent suicidal behaviour, despite growing 
understanding of the aetiology of suicidality. Clinical guidelines recommend that health care 
professionals develop a safety plan in collaboration with their high-risk patients, to lower the 
imminent risk of suicidal behaviour. Mobile health applications provide new opportunities for 
safety planning, and enable daily self-monitoring of suicide-related symptoms that may 
enhance safety planning. This paper presents the rationale and protocol of the Continuous 
Assessment for Suicide Prevention And Research (CASPAR) study. The aim of the study is 
two-fold: to evaluate the feasibility of mobile safety planning and daily mobile self-
monitoring in routine care treatment for suicidal patients, and to conduct fundamental 
research on suicidal processes.  
Methods: The study is an adaptive single cohort design among 80 adult outpatients or day-
care patients, with the main diagnosis of major depressive disorder or dysthymia, who have an 
increased risk for suicidal behaviours. There are three measurement points, at baseline, at 1 
and 3 months after baseline. Patients are instructed to use their mobile safety plan when 
necessary and monitor their suicidal symptoms daily. Both these apps will be used in 
treatment with their clinician.  
Conclusion: The results from this study will provide insight into the feasibility of mobile 
safety planning and self-monitoring in treatment of suicidal patients. Furthermore, knowledge 
of the suicidal process will be enhanced, especially regarding the transition from suicidal 
ideation to behaviour.  
 
The study protocol is currently under revision for medical ethics approval by the Medical 
Ethics Committee of the Vrije Universiteit Medical centre Amsterdam (METc number 
2017.512/NL62795.029.17).   
 
Keywords: suicide prevention; mobile health; feasibility; safety planning; ecological 
momentary assessment 
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1. Introduction 
Suicide is a significant public health issue worldwide, with an estimated 800,000 suicides 
each year. Despite global efforts to reduce suicides 1, suicide rates have either remained 
constant or risen in many countries in recent years 2. This highlights the need to better 
understand and prevent suicidal behaviour 2. 
Several studies have targeted the aetiology of suicidality, and our understanding of 
factors associated with suicide has grown considerably over the last decade 3. Many of the 
studies on risk factors associated with suicidality have focused on bivariate associations 
between epidemiological factors, such as the prevalence of psychopathology and suicidal 
behaviours 2. These distal risk factors are important from a general public health perspective, 
but are of limited clinical use in the identification and treatment of individuals who are at risk 
of acting on their thoughts of suicide 2,4,5.  
In order to better understand and prevent suicidal behaviour in the clinical sector, the 
Continuous Assessment for Suicide Prevention And Research (CASPAR) study combines 
practice-based research with basic science. This paper describes the rationale and protocol of 
this study.  
 
1.1. Theoretic framework 
Most people who think about suicide (suicide ideators) do not attempt suicide, and not every 
transition from thoughts to suicidal behaviour results in a fatal suicide attempt 6. For each 
adult who dies by suicide, it is estimated that more than 20 others make a non-fatal suicide 
attempt 1. To enhance suicide prevention methods in treatment, it is crucial to understand the 
factors that differentiate people who only think about suicide from those who act on their 
thoughts.  
Suicidal behaviour is often defined as the whole of thoughts and behaviours related to 
an individual considering or taking their own life 4. In this study however, we make a 
distinction between suicidal ideation and suicidal behaviour per se, as the intention to engage 
in suicidal behaviour and acting on that intention are two different processes 7. Suicidal 
ideation will be defined as thinking about, considering, imagining or planning suicide, 
whereas suicidal behaviour is defined as engagement in potentially self-injurious behaviour 
with the intent to die (suicide attempts, both non-fatal and fatal) 8.  
In order to reflect the difference between ideation and behaviour, the ‘ideation-to-
action’ framework of Klonsky and May 6 suggests that there are distinct risk factors for 
suicidal ideation and suicidal behaviour. Consistent with the ‘ideation-to-action’ framework, 
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the integrated motivational-volitional (IMV) model of suicidal behaviour developed by 
O’Connor 7 distinguishes between factors associated with ideation and behaviour. The IMV 
model integrates key factors from earlier theories to map the transition from suicidal thoughts 
to suicidal behaviour, among which: the Theory of Planned Behaviour 9, the diathesis-stress 
hypothesis 10, the escape theory 11, the arrested flight model of suicidal behaviour 12 and the 
Interpersonal-Psychological model 13. In the IMV model, suicidal behaviour is conceptualised 
as behaviour that develops through pre-motivational, motivational and volitional phases and it 
has been recently refined (Figure 1) 7,14. 
The pre-motivational phase covers biosocial factors such as background factors (e.g. 
deprivation) and trigger events (e.g. negative life events). It describes the underlying cognitive 
vulnerability of a person as the result of the interaction between nature and nurture. The 
motivational phase defines the development of suicidal ideation and intent. It is predicted that 
feelings of entrapment are triggered by the experience of defeat. This transition is moderated 
by threat to self moderators such as coping and ruminative processes. Feelings of entrapment 
will trigger the development of suicidal ideation, moderated by motivational factors such as 
burdensomeness and dysfunctional thoughts about the future. The volitional phase is the last 
phase, and covers factors that govern the transition from suicidal thinking to suicidal 
behaviour. It is hypothesised that this transition is moderated by volitional moderators such as 
impulsivity, exposure to the suicidal behaviour of others, and the personal capacity for 
carrying out suicide 4,7,15. More information about the IMV model can be found in O’Connor 
(2011) 7 and O’Connor and Kirtley (in press) 14.  
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Figure 1. The integrated motivational-volitional (IMV) model of suicidal behaviour (from 
O’Connor and Kirtley (in press) 14). 
 
1.2. Safety Planning  
Safety planning is a clinical intervention component often included in the treatment of 
suicidal patients, and specifically aimed at the transition from having the thoughts/intention to 
engage in suicidal behaviours and acting upon the thoughts/intention. The research literature 
describes different methods of safety planning, including the safety planning intervention 16,17 
and the crisis response plan 18, but these methods are built on the same principles. A safety 
plan is a list of coping strategies and interventions  (e.g., what patients can do when they are 
in an imminent suicidal crisis), written down on paper by the patient together with a clinician, 
in order to prevent suicidal behaviour 16. This intervention is used in clinical practice, with the 
intention of enhancing the safety of high-risk suicidal patients by planning responses to 
impending suicidal crises (e.g. patients characterised by significant suicidal ideation, suicidal 
intent, suicidal plan, or/and a recent suicide attempt) 19. The basic premise underpinning the 
safety plan approach is that patients can recognise and manage their suicidal thoughts and 
behaviours. Patients improve their self-management when faced with an imminent suicidal 
crisis, hereby addressing the problem before it fully emerges and preventing the impending 
suicidal behaviour 16. 
 The use of safety planning strategies is primarily based on clinicians’ beliefs about 
their effectiveness 20. Even though safety planning has not yet been definitively tested 21, it is 
recommended for patients at risk of suicide in suicide prevention guidelines 22 and care 
quality standards (https://www.nice.org.uk/guidance/qs34/chapter/Quality-statement-6-Risk-
management-plans) and safety plans are embedded in Cognitive Behavioural Therapy for 
suicide prevention 23. Safety planning can also be considered a required safety net for research 
projects involving suicidal patients. As safety plans are already embedded in treatment 
protocols, it is difficult to test their effectiveness empirically. Fortunately, evidence for safety 
plans is building. In a recent RCT among US soldiers at high risk of suicide, Bryan et al. 20 
found crisis response safety planning, an intervention related to safety planning, to be 
effective in preventing suicide attempts compared to the use of contracts for safety (which 
entails a commitment from the suicidal patient to avoid engaging in suicidal behaviour).  
A systematic and comprehensive method of safety planning commonly used in clinical 
practice is the safety planning intervention (SPI) developed by Stanley and Brown 16,17. The 
SPI consists of six steps: 1) identifying early warning signs of an impending suicidal crisis 
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(e.g. negative feelings and problematic behaviours); 2) employing internal coping strategies; 
3) employing distraction activities and socialisation to distract from suicidal ideation; 4) 
making use of social support contacts who may offer help; 5) collating the contact details of 
mental health professionals and other crisis resources; and 6) making the environment safe 16. 
These steps are personalised by the suicidal patients and their clinician in a collaborative 
process during treatment and written in the patient’s own words. When a patient is able to 
identify personal negative feelings and problematic behaviours associated with their 
suicidality, these can be a cue for the patient to use their personal safety plan in order to 
obstruct the transition to suicidal behaviours 16.  
Safety plans are commonly written down on paper, implying they are either carried 
around or stored at the patients’ home. Paper safety plans may therefore not always be at hand 
in times of crisis, which is crucial considering the fluid nature of suicidal processes 24. There 
is a need for more flexible and adaptive resources for suicidal patients. The use of novel 
mobile technologies may improve the accessibility and usability of safety plans and can 
include interactive elements which make safety planning more dynamic.  
 
1.3. Mobile mental health  
Mobile technology provides new opportunities for mental health care and suicide prevention. 
Customised applications (apps) can be run on mobile devices to provide, for example, 
emotional support and behavioural coaching. Apps can be especially useful for suicide 
prevention interventions, because of their ability to deliver support and interventions in situ 
and at times of crisis, as suicide ideation and behaviour can change rapidly 25. There are 
multiple apps designed to target suicidal behaviour. According to a systematic assessment of 
publicly available smartphone tools for suicide prevention 25, most available apps focus on 
safety planning or/and obtaining support from the user’s social networks. A report that studied 
available suicide prevention apps in the Apple Store (iOS) and Play Store (Android) 
concluded that it was not possible to indicate whether the provenance of the suicide apps was 
evidence-based, owing to the lack of information regarding how the app content was 
developed and tested 26.  
Besides new opportunities for interventions, mobile technology also provides 
opportunities for psychological research. Self-monitoring techniques such as experience 
sampling or ecological momentary assessment (EMA) 27 have been used to monitor 
psychological processes by daily repeated self-report questions prompted by ‘beeps’ at 
random times throughout the day 28. In recent years, the use of EMA in clinical research 
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contexts has rapidly increased. In addition, some studies 29–31 have reported behavioural 
changes in participants over the EMA monitoring period, which may suggest that self-
monitoring constitutes a therapeutic intervention in itself. Insights into the nature and 
dynamics of patients’ own symptomatology may engender feelings of control and 
empowerment in relation to their symptoms 32.  
By employing EMA in suicide research it may be possible to monitor the transition 
from suicidal thoughts to suicidal behaviour in real time 33–35. Multiple studies have 
demonstrated the feasibility of electronic monitoring of suicidal ideation, using hand-held 
computers 36,37. Results of these studies indicate that the repeated measures did not increase 
negative thoughts or suicidal ideation. This is consistent with retrospective reports indicating 
that the urge to self-harm does not increase after retrospective assessment of suicidal ideation 
38.  
A recent study by Kleiman et al. 39 examined fluctuations in suicidal ideation and its 
risk factors (e.g. hopelessness, burdensomeness and loneliness) using EMA on smartphones. 
They found that suicidal ideation and its risk factors fluctuate considerably over the course of 
hours. This study also attests to the feasibility of using smartphone-based EMA in research 
and in the treatment of suicidal patients. Since the rapid changes in suicidal ideation and its 
risk factors might be assessable via EMA, Kleiman et al. 39 suggest that interventions can 
benefit from EMA by tracking and reacting to dynamic suicidal processes in real-time. 
 
1.4. Study objectives 
The CASPAR study has a two-fold design in which practice-based research is combined with 
basic science. The first part of this study will be an evaluation of the feasibility (i.e. usability, 
satisfaction and uptake) of mobile safety planning and daily mobile self-monitoring in routine 
care treatment for suicidal patients. The second part will comprise fundamental research into 
suicidal processes, for which we have three aims: 1) validate the IMV model concerning 
psychological processes associated with suicidal behaviour; 2) identify individual pathways to 
suicidal behaviour; and 3) profile sub-types of suicidal individuals.  
 
2. Method 
2.1. Participants 
The research population will consist of at least 80 adult outpatients or day-care patients in 
mental health care in the Netherlands who suffer from a major depressive disorder or 
dysthymia, and who are at elevated risk of suicidal behaviour because they engage in suicidal 
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ideation. Participants will be recruited from 3 mental health organisations in the Netherlands. 
Written informed consent will be obtained from each participant.  
 The sample size is not based on a sample size calculation, because the primary 
outcomes of this study are not dependent on effect sizes. For feasibility studies, a sample size 
of around 60 has been recommended 40. Because of an expected 25% drop-out rate, we will 
recruit 80 participants. In respect of the secondary analyses, the high frequency measurement 
approach of EMA provides ample power for structural equation models to test the validity of 
theoretical models.  
 The CASPAR study protocol is currently under revision for medical ethics approval 
by the Vrije Universiteit Medical centre Amsterdam (METc number:  
2017.512/NL62795.029.17) .  
 
2.2. Inclusion criteria  
To be eligible to participate, patients must meet the following criteria:  
 Outpatient or day-care patient; 
 Main diagnosis of major depressive disorder or dysthymia; 
 Current suicidal ideation; 
 18 years or older;  
 In possession of a smartphone that runs either on Android or iOS. 
 
2.3. Exclusion criteria  
Patients are excluded from participation when they meet the following criteria:  
 Insufficient competence in the Dutch language;  
 Presence of psychotic symptoms; 
 Not willing or able to use smartphone apps.  
 
2.4. Outcome measures of part 1: practice-based research 
Primary outcome of part 1 is feasibility. We define feasibility by three related variables: 
usability, acceptability and uptake.   
Usability of the mobile applications is measured with the System Usability Scale 
(SUS) 41,42. This scale consists of 10 questions, with a higher score representing higher 
usability. Based on several studies, Bangor et al. 42 recommend that a SUS score above 70 can 
be considered adequate. Hence, we consider a SUS-score of 70 or more to be suitable. We 
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translated the SUS into Dutch using forward- and blind backward-translation. The CASPAR 
study will be the first study to use this translated questionnaire.  
 Satisfaction with the mobile applications is measured with the Client Satisfaction 
Questionnaire-8 (CSQ-8) 43. The CSQ is a standardised measure consisting of 8 questions to 
assess the patient’s perspective on client satisfaction with the service. This questionnaire has 
good psychometric properties 44,45. We will use the Dutch version of the Client Satisfaction 
Questionnaire-8 (CSQ-8), translated from English by De Brey 46. The items can be answered 
on a scale from 1 to 4, with a total score on a range from 8 to 32. We consider a score of 20 or 
higher to be acceptable.  
Uptake is operationalised as: 1) 75% of the patients complete the safety plan which is 
measured by retrospective questions; 2) 75% of the patients complete at least 50% of the self-
monitoring questions during the second and third month of the study measured by analyses of 
the EMA data, and 3) 75% of the patients discuss the safety plan and self-monitoring at least 
once every two weeks with their clinician, measured by clinician feedback.  
 
2.5. Outcome measures of part 2: fundamental research  
The primary outcome measure of part 2 is the level of explorative power of the IMV model 7. 
The secondary outcomes are to determine pathways to suicidal behaviour and to determine 
subtypes of suicidal individuals. To assess these three outcomes we have operationalized the 
phases and corresponding constructs described within the IMV model (Figure 1), using both 
full scale questionnaires and single items selected from questionnaires (see Appendix 1 for the 
single items). 
The pre-motivational phase of the IMV model, which consists of background factors 
and triggering events, is assessed by demographic questions. Anxiety is measured with the 
GAD-7, a self-report questionnaire with good psychometric properties 47. The GAD-7 has 7 
items (e.g. “Feeling nervous, anxious or on edge”) which are rated on a 4-point scale ranging 
from 0 (not at all) to 3 (nearly every day). Depression is measured with the Patient Health 
Questionnaire-9 (PHQ-9), a self-report questionnaire of 9 items (e.g. “Feeling down, 
depressed, or hopeless”) to measure depression severity on a 4-point scale ranging from 0 
(not at all) to 3 (nearly every day). The PHQ-9 has adequate psychometric properties 48.  
 The motivational phase of the IMV model represents the formation of suicidal 
ideation and intent. Suicidal ideation and intent are measured with items from the Beck Scale 
for Suicide Ideation (BSS) 49. Feelings of defeat and entrapment are measured with the Short 
Defeat and Entrapment Scale (SDES). The SDES has 8 items (e.g. “I feel defeated by life”) 
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which are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely like me). The 
psychometric properties of the SDES are adequate 50.  The SDES was translated into Dutch by 
using forward-translation (translated and discussed by two independent health professionals) 
and blind backward-translation (by an independent translator whose primarily language is 
English). 
 The volitional phase of the IMV model covers behavioural enaction. Suicidal 
behaviour is assessed with questions from the Self-Injurious Thoughts and Behaviours 
Interview (SITBI). The SITBI assesses multiple suicide-related constructs, including recent 
and past suicidal ideation, plans, gestures and attempts. In its original form, the SITBI is a 
structured interview with good psychometric properties 51. For the CASPAR study, questions 
were selected and translated into Dutch using forward- and blind backward-translation. We 
adapted the interview questions into self-report questions.  
The different phases of the IMV model contain multiple moderators, which are 
operationalised in the CASPAR study as well. Threat to self moderators are assessed via 
several questionnaires. Ruminative processes are assessed with single items originating from 
the GAD-7 47 and the Ruminative Responses Scale (RRS) which is a self-report measure of 
rumination 52. Coping, another threat to self moderator, is measured with items from the 
Utrechtse Coping Lijst (UCL). The UCL is a self-report questionnaire to assess people’s 
coping strategies 53.      
Motivational moderators within the IMV model are assessed with various 
questionnaires. Interpersonal needs are assessed with the self-report Interpersonal Needs 
Questionnaire-12 (INQ-12). The INQ-12 contains 12 items (e.g. “These days the people in my 
life would be better off if I were gone”) rated on a 7-point scale ranging from 1 (not at all true 
for me) to 7 (very true for me) and has good psychometric properties 54,55 . This questionnaire 
was translated into Dutch by 113 Suicide Prevention (the Dutch national suicide helpline) 
using forward- and backward-translation. One item from the Brief Resilience Scale (BRS) 56 
is used to measure resilience and multiple items of the Reasons for Living Inventory (RFL-A) 
57 are used to assess future thoughts. These items were translated into Dutch by using 
forward- and backward-translation.   
Some of the volitional moderators are assessed with the Acquired Capability for 
Suicide Scale (ACSS), a self-report questionnaire. The ACSS is a 5-item measure (e.g. “I am 
not at all afraid to die”) with adequate psychometric properties to assess fearlessness about 
lethal self-injury 58. Items are rated on a 5-point scale ranging from 0 (not at all like me) to 4 
(very much like me). The ACSS was translated into Dutch by 113 Suicide Prevention using 
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forward- and blind backward-translation. Impulsivity is another volitional moderator, 
measured with the Urgency, Premeditation, Perseverance, Sensation seeking, Positive 
Urgency Impulsive Behaviour Scale (UPPS-P) 59. Suicide-related mental imagery is seen as a 
volitional moderator. The CASPAR study assessed imagery with items from the Social 
cognitions and Flash-forwards Interview (Imagery Interview) 60. The Imagery Interview and 
the UPPS-P have been translated into Dutch using forward- and backward-translation.  
The CASPAR study will be the first study to use the above mentioned translated 
questionnaires.  
 
2.6. Interventions 
The CASPAR study will investigate two mobile applications: safety planning and daily self-
monitoring. For the safety planning app we will use BackUp. This app has been developed by 
the Vlaams Expertisecentrum Suïcidepreventie (VLESP) for use in Flanders, Belgium. A 
version for use in the Netherlands, with minor changes regarding the interface, has been 
developed in collaboration with 113 Suicide Prevention. The safety plan in BackUp is based 
on Stanley and Brown’s Safety Planning Intervention16, and it contains the same 6 steps as the 
original safety plan (e.g. warning signs, internal coping strategies, distracting activities, social 
support, contacting mental health professionals, making the environment safe).  
For the self-monitoring app we will use the mEMA app, which had been developed by 
Ilumivu (https://ilumivu.com/). The mEMA app will monitor suicidal processes by daily 
repeated self-report questions prompted by ‘beeps’ at random moments. The mEMA app 
computes a graph of all variables through time, which is visible to the patient. At the 
beginning of the study we will present 8 items to the patient at 3 random intervals a day. In 
addition to these assessments, the patients are prompted to complete an evening list consisting 
of 8 items. Based on feedback from patients we will adapt the self-monitoring questions, the 
number of questions at each beep and the number of beeps.  
We chose the self-monitoring questions based on constructs mentioned within the 
IMV model. For each construct we selected established retrospective questionnaires that 
assess the constructs (see section 2.5. Outcome measures of part 2: fundamental research) and 
we re-wrote the question in a more immediate (momentary) form. For example, the 
Generalized Anxiety Disorder-7 is a questionnaire which assesses anxiety symptoms in the 
last two weeks. The item ‘Being so restless that it’s hard to sit still’ had been re-written for the 
CASPAR study as ‘I feel restless’ to make the item more assessable in real time.  
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mEMA will also gather unobtrusive measures that will accumulate automatically on 
the patient’s mobile phone. Every self-monitoring assessment will include location data based 
on GPS, if has been activated by the patient. Accelerometer data is also collected 
continuously. 
 
2.7. Design  
The CASPAR study is a single cohort design among patients from three mental health centres. 
There will be three measurement points: T0 (baseline), T1 (one month after T0) and T2 (three 
months after T0). We consider this study to be an adaptive design, which means that the two 
apps that we investigate will be improved based on patient feedback. As a result, the apps 
may change slightly during the study.  
 
2.8. Procedure 
Clinicians from the participating mental health organisations will be invited to participate in 
the CASPAR study. Participating clinicians will receive training from the researchers on 
using both the safety planning app and self-monitoring app add-ons in regular treatment with 
their patients. Participating clinicians will select patients from their caseload based on the 
inclusion criteria and the clinician’s experience with the patient. The clinician will then invite 
the patient to participate in the CASPAR study and provide them with further information. 
CASPAR is additional to regular treatment and it will be made clear that non-participation 
will have no negative consequences for patients.    
 If the patient is willing to participate, the researchers will invite the patient for the first 
measurement session (baseline; T0) in a face-to-face meeting. The patient will sign the 
informed consent form and answer 5 questionnaires (i.e. ACSS, GAD-7, INQ-12, PHQ-9 and 
SDES) and multiple single items from questionnaires (i.e. BRS, BSS, Imagery Interview, 
RFL-A, RRS, SITBI, UCL and UPPS-P). Furthermore, the researcher will install both the 
BackUp app and the mEMA app on the patient’s smartphone and explain both apps in detail. 
The patient starts using the apps after T0. The mEMA app will prompt the patient to answer 
multiple self-monitoring questions throughout the day. The patient and clinician will complete 
the BackUp safety plan in the first (clinical) session after T0, from that moment on the patient 
can use the BackUp app if necessary. Both these apps will be used during the patient’s regular 
treatment. For example, the mEMA graph of the self-monitoring questions the patient has 
filled in can be used to discuss the patient’s symptoms and subsequently be added to the 
safety plan on the BackUp app.  
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 One month after T0 a researcher will contact the patient by phone for general feedback 
on the apps. The researcher will send the second measurement questions (T1) to the patient 
via an online survey tool. The patient is invited to answer the same questionnaires as at T0, 
and two additional questionnaires related to the feasibility endpoints (i.e. CSQ and SUS). 
After completing T1, the patient will continue to use both apps and they will be used in 
treatment.   
 Three months after baseline (T2) the researcher will contact the patient again by phone 
for general feedback on the apps. The patient will be invited to answer the same questions as 
at T1, which the researcher will send via the online survey tool. After completing T2, the 
patient and clinician will decide whether to keep using the apps (either or both). If the patient 
wants to stop using the apps, or when the patient is discharged from treatment, the clinician 
will assist in uninstalling the apps from the patient’s smartphone.  
 
2.9. Incentives 
Patients will receive Bol.com discount codes worth 5 Euro after every completed 
measurement point (i.e. T0, T1, T2), as well as when they have completed over 60% of the 
self-report questions between T0 and T1. Patients can receive a maximum of 20 Euro for 
participation.  
 
2.10. Analyses (Statistical methods)   
The primary outcomes are feasibility measures, i.e. uptake, patient satisfaction and usability, 
and will be presented using descriptive statistics. For the secondary outcome measures we 
will analyse the self-monitoring data. Our approach to validating psychological processes and 
stages of suicide pathways as outlined by the IMV model of O’Connor 7 is a structural 
equation model. The IMV model postulates phases, variables per phase, temporal relations 
and moderated relations between variables. We will test these hypothesised relations until we 
find the optimal model. Because the self-monitoring data consist of time-series data with 
irregular intervals between measurement points, we will apply continuous time modelling 
(e.g. Ryan et al. 61), in which time is viewed as a continuous variable. This modelling 
technique is robust for different intervals between measurement points, as well as for missing 
data.  
 For identifying individual pathways to suicidal behaviour, we will focus on both the 
individual and subgroup level. We will conduct a longitudinal network analysis applying 
vector-autoregression (VAR; e.g. Basu et al. 62). Temporal networks of subgroups will be 
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analysed using multilevel VAR. Finally, latent class growth analyses 63 will be conducted to 
identify subgroups based on variable trajectories over time. Analyses will be carried out in R, 
using various packages such as lavaan, ctsem, mlVAR and bootnet.  
 
3. Discussion  
The CASPAR study combines practice-based research with fundamental research in order to 
enhance suicide prevention methods and theories targeting the transition phase from suicidal 
thinking to suicidal behaviour. With this two-fold study we aim to contribute to the field of 
suicide prevention and mobile health in the following ways. First, we will assess the 
feasibility of integrating mobile health interventions (i.e. safety planning and self-monitoring) 
into the routine care and treatment of suicidal patients. Second, central constructs of 
suicidality will be assessed at a symptom level and in real-time, hereby providing insight into 
the mental health of suicidal patients. While patients can use these data for self-monitoring 
and self-management, clinicians can use this information directly in treatment. We assume 
that the combination of a mobile safety plan and daily self-monitoring will lead to a decrease 
in suicidal symptoms, and ultimately to fewer suicide attempts (although this is beyond the 
scope of the present study). Third, analyses of the EMA data will be used to enhance current 
knowledge of the suicidal process, especially regarding the transition from suicidal ideation to 
behaviour. This will help in the identification and treatment of individuals who are at risk of 
acting on their thoughts of suicide.  
 If the use of applications is feasible for patients, the next step would be to combine 
mobile safety-planning and self-monitoring apps. It could be possible to trigger the safety 
plan app based on self-monitoring answers. Such an intervention is called an ecological 
momentary intervention (EMI) 64. EMIs are able to make use of information about the user 
and their related environment, by gathering self-monitoring data (EMA), in order to optimize 
the intervention delivery. In this way it becomes possible for EMIs to provide support to 
patients when they need it the most. With the rapidly changing nature of suicidality, patients 
are likely to benefit from this kind of intervention. 
 
4. Conclusion  
This paper describes the study protocol of the CASPAR study. The CASPAR study is 
designed to evaluate the feasibility of safety planning and self-monitoring in the treatment of 
suicidal patients. Furthermore, the CASPAR study will apply basic science methods to 
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advance understanding of dynamic suicidal processes thereby increasing knowledge of the 
proximal risk factors of suicidality.  
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Trial status 
At the time of the revised manuscript submission, the study is in a preparatory phase. The 
protocol is under revision for medical ethical approval by the Vrije Universiteit Medical 
center (METc number: 2017.512/NL62795.029.17). The first patients are expected to be 
included in August 2018.  
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Appendix 1, single item questions  
 Nr. Item 
RFL-A 4 I have a desire to live. 
13 I have future plans I am looking forward to carrying out 
40 I  have hope that things will improve and the future will be happier 
BRS 5 Tend to bounce back after illness or hardship 
UCL 10 I can discuss my concerns with someone 
46 I do not feel able to do anything 
UPPS 2 I have trouble controlling my impulses. 
48 I usually think carefully before doing anything. 
RRS 12 I think about a recent event of which I wish it had gone better 
24 I think ‘What am I doing to deserve this?’ 
BSS 4 I have the desire to make kill myself 
12 I have a specific plan how I can to kill myself 
SITBI-SF 2 How old were you the first time you had thoughts of killing yourself?  
4 During how many separate times in your life have you had thoughts of killing 
yourself? 
5 How many separate times in the past year? 
6 How many separate times in the past month? 
7 How many separate times in the past week? 
8 When was the last time?  
9 On this scale of 0 to 4, at the worst point how intense were your thoughts of 
killing yourself? 
10 On average, how intense were these thoughts?  
14 Have you ever actually made a plan to kill yourself?  
22 On average, how seriously have you considered acting on them?  
23 When you’ve had a plan, what method did you think of using? 
36 Have you ever made an actual attempt to kill yourself in which you had at least 
some intent to die? 
37 How old were you the first time you made a suicide attempt?  
38 When was the most recent attempt?  
40 How many suicide attempts have you made in your lifetime?   
41 How many have you made in the past year?  
42 How many have you made in the past month?  
43 How many have you made in the past week? 
44 What method did you use for your most recent attempt? 
50 On the scale of 0 to 4, what do you think the likelihood is that you will make a 
suicide attempt in the future? 
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Highlights  
 
Smartphone-based safety planning and self-monitoring for suicidal patients: rationale and study 
protocol of the CASPAR (Continuous Assessment for Suicide Prevention And Research) study 
 
 Mobile applications provide opportunities to enhance suicide prevention methods.  
 Personal safety plans for suicidal patients can be augmented by self-monitoring data of mental 
states.  
 Dynamic suicidal processes can be investigated in real-time using self-monitoring data.  
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